SARS-CoV-2 vaccines - the biggest medical research project of the 21st century.

SARS-CoV-2 vaccines - the biggest medical research project of the 21st century.
复制标题

DOI:
10.1016/j.coviro.2021.04.008
复制
发表时间:
2021-08
影响因子:
5.9
通讯作者:
Schnell MJ
Schnell MJ
中科院分区:
医学2区
文献类型:
--
作者:
Kurup D;Schnell MJ

文献摘要

参考文献

被引文献

相似文献

SARS-CoV-2已在全球超过1.41亿人中发现,并造成300多万人死亡。为了在达到自然免疫力之前减少数百万人的额外生命损失,研究人员专注于阻止COVID-19大流行的唯一已知方法:疫苗。这场大流行推动了疫苗的高速发展,其中一些疫苗是基于疫苗领域以前没有使用过的新技术。新技术带来了新的可能性,但也带来了挑战,因为新平台的长期性能尚不清楚。在这里,我们回顾了目前针对COVID-19的主要候选疫苗,并概述了每种候选疫苗的优点和缺点以及未知因素。
SARS-CoV-2 has been detected in more than 141 million people and caused more than 3 million deaths worldwide. To reduce the additional loss of millions of lives until natural immunity is reached, researchers have focused on the only known method to stop the COVID-19 pandemic: vaccines. The pandemic has propelled high-speed vaccine development, some based on novel technology previously not utilized in the vaccine field. The new technology opens new possibilities and comes with challenges because the long-term performance of the new platforms is unknown. Here we review the current leading vaccine candidates against COVID-19 and outline the advantages and disadvantages as well as the unknowns of each candidate.
BNT162B2 mRNA COVID-19疫苗的安全性和功效。
DOI: 10.1056/nejmoa2034577
发表时间: 2020-12-31
期刊: The New England journal of medicine
影响因子: --
作者:
Polack FP;Thomas SJ;Kitchin N;Absalon J;Gurtman A;Lockhart S;Perez JL;Pérez Marc G;Moreira ED;Zerbini C;Bailey R;Swanson KA;Roychoudhury S;Koury K;Li P;Kalina WV;Cooper D;Frenck RW Jr;Hammitt LL;Türeci Ö;Nell H;Schaefer A;Ünal S;Tresnan DB;Mather S;Dormitzer PR;Şahin U;Jansen KU;Gruber WC;C4591001 Clinical Trial Group
通讯作者: C4591001 Clinical Trial Group
DOI: 10.1016/s1473-3099(20)30476-x
发表时间: 2021-03-24
影响因子: 56.3
作者:
Pollard, Andrew J.;Launay, Odile;Thiebaut, Rodolphe
通讯作者: Thiebaut, Rodolphe
DOI: 10.1101/2020.06.15.153387
发表时间: 2021-01-01
期刊: JACC. Basic to translational science
影响因子: --
作者:
Beddingfield, Brandon J;Iwanaga, Naoki;Bix, Gregory J
通讯作者: Bix, Gregory J
DOI: 10.1056/nejmoa2026920
发表时间: 2020-12-10
影响因子: 158.5
作者:
Keech, Cheryl;Albert, Gary;Glenn, Gregory M.
通讯作者: Glenn, Gregory M.
DOI: 10.1056/nejmoa2035389
发表时间: 2021-02-04
期刊: The New England journal of medicine
影响因子: --
作者:
Baden LR;El Sahly HM;Essink B;Kotloff K;Frey S;Novak R;Diemert D;Spector SA;Rouphael N;Creech CB;McGettigan J;Khetan S;Segall N;Solis J;Brosz A;Fierro C;Schwartz H;Neuzil K;Corey L;Gilbert P;Janes H;Follmann D;Marovich M;Mascola J;Polakowski L;Ledgerwood J;Graham BS;Bennett H;Pajon R;Knightly C;Leav B;Deng W;Zhou H;Han S;Ivarsson M;Miller J;Zaks T;COVE Study Group
通讯作者: COVE Study Group